Nanion User Meeting USA 2018

Nanion User Meeting USA 2018

By Nanion Technologies GmbH

Date and time

June 21, 2018 · 7:30am - June 22, 2018 · 3:30pm EDT

Location

Hyatt Regency Hotel

575 Memorial Dr. Cambridge, MA 02139

Description

The 2018 Nanion User Meeting USA will be held at the Hyatt Regency hotel in Cambridge USA.


> Symposium will be organized on the 21th of June, where we welcome our users and collaboration partners to present their most recent data and research of interest.


  • Speakers:

Keynote: Prof. Dr. Christine Beeton, Baylor College, Texas, USA.
Title: Targeting potassium channels in rheumatoid arthritis."

Keynote: Dr. Mark Estacion, Yale School of Medicine, USA
Title: Precision medicine targeting pain: progress finding treatments for specific NaV1.7 mutations."

Dr. Stephen Hess, Evotec, Hamburg Germany

Title: "Finding Nav1.1 Enhancers on the SyncroPatch 384PE"

Dr. David Jones, University of Wisconsin-Madison.
Title: "Targeting hERG K+ channel intracellular domains to manipulate channel function and cardiac repolarization"

Dr. Jun Chen, Genentech, Inc.
Title: "Molecular mechanisms for the activation and block of TRPA1 channel"

Dr. Al George Jr., Northwestern Medicine.
Title: "Decrypting variants of unknown significance in the channelopathies"

Dr. Shan Parikh, Vanderbilt University Medical Center.
Title: "High throughput investigation of contractile and electrophysiological properties of optically stimulated hiPSC-CM monolayers"

Dr. Stefan Braam, Ncardia.
Title: "iPSC derived cells in drug discovery and development"

Dr. Gary Aistrup, Masonic Medical Research Institute (MMRI), USA
Title: "CardioExcyte and SyncroPatch 384 High Throughput Assessment of Functional Abnormalities of Patient-Specific iPSC-CMs Harboring Multiple Mutations"

Dr. Jürgen Bosch, Case Western Reserve University.
Title: "Are two channels enough? The search for the missing piece."

Dr. Nicholas Last, Howard Hughes Medical Institute / Brandeis University.
Title: "Characterization of the curious pores of the Fluc fluoride channel with the Orbit Mini"

Dr. Scott MacDonnell, Regeneron Pharmaceuticals.
Title: “Evaluation of MYH7-R403Q Patient-Derived iPSC Cardiomyocytes as an In-Vitro Model of Hypertrophic Cardiomyopathy”

Dr. Sami Noujaim, University South Florida
Title: "Antiarrhythmic Potential of Antimalarial Aminoquinolines

Dr. Andrea Brüggemann, Nanion Technologies.
Title: "Applications of the SyncroPatch 384PE: Safety Pharmacology and more."


More information to follow:

Please register for our Newsletter or visit or Website "Nanion User Meeting USA 2018" for updates.


Call for posters:

Posters will be on display for the whole day on June 21th; submission is free of charge, please contact corina.bot@naniontech.com with a title and brief abstract before May 21st Note: Poster boards can accommodate 2ft by 2.5ft or 3x4ft posters.

Organized by

Nanion Technologies GmbH is a German Private Limited Company and was founded in 2002 as a spin-off from the Center for Nanoscience (CeNS) of the University of Munich.

Nanion Technologies supplies leading ion channel drug discovery and screening technologies: Our portfolio comprises patch clamp technology for sophisticated and high throughput applications (Port-a-Patch, Patchliner, SyncroPatch 384/768PE), impedance recordings (CardioExcyte 96), parallel bilayer recordings (Orbit mini & Orbit 16), and parallel membrane transporter protein recordings (SURFE²R N1 & SURFE²R 96SE).

Sales Ended